Xeris Biopharma Holdings, Inc. (XERS)
7.17
+0.16
(+2.28%)
USD |
NASDAQ |
Dec 12, 16:00
7.21
+0.04
(+0.56%)
After-Hours: 20:00
Xeris Biopharma Holdings Cash from Investing (Quarterly): -0.071M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -3.812M |
| Amneal Pharmaceuticals, Inc. | -22.46M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 18.43M |
| Cash from Financing (Quarterly) | 13.85M |
| Free Cash Flow | 9.975M |
| Free Cash Flow Per Share (Quarterly) | 0.1034 |
| Free Cash Flow to Equity (Quarterly) | 17.93M |
| Free Cash Flow to Firm (Quarterly) | 25.63M |
| Free Cash Flow Yield | 0.87% |